IL17A and neoplasm: The microbiome also modulates the Th17/Treg balance within the TME, influencing cytokine production that can either promote inflammation and anti-tumor immunity (e.g., IFN-γ, IL-17) or suppress immune responses (e.g., IL-10 from Tregs or regulatory Th17 cells) [179, 182].